Antibody Therapeutics against Infectious Disease
A special issue of Bioengineering (ISSN 2306-5354).
Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 465
Special Issue Editors
Interests: recombinant protein production; monoclonal antibodies; Chinese hamster ovary cells; omics, biomanufacturing; biosimilars; protein glycosylation; bioreactors
Special Issues, Collections and Topics in MDPI journals
Interests: biopharmaceutical; ocular drug delivery; antibody-based medicine; protein conjugation and characterization; binding assays; antibody formulation; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bioengineering is currently soliciting manuscripts for a special issue focusing on novel antibody therapeutics used to treat infectious disease. Manuscripts can include literature reviews as well as primary research papers. Topics of particular interest include platforms for rapid discovery of antibodies, bispecific antibodies, strategies for rapid manufacturing to respond to emerging diseases, and repurposing of existing antibody therapeutics for novel indications in infectious disease. Submissions related to treatment of SARS-CoV2/COVID19 are particularly encouraged, but papers addressing other infectious diseases such as respiratory syncytial virus (RSV), Zika and Ebola viruses are also welcome.
Submissions are requested by May 2021 and will be peer-reviewed and published once submitted, possible publication date September 2021. Bioengineering (ISSN 2306-5354; CODEN: BIOENG) is an international scientific peer-reviewed, open access journal on the science and technology of bioengineering, published monthly online by MDPI.
Prof. Dr. Susan Sharfstein
Dr. Hanieh Khalili
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
